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MICROFLUIDIC DEVICE FOR RAPID DETECTION 
OF FIBRINOLYSIS OF BLOOD CLOTS 
HAN JIANG 
ABSTRACT 
This thesis presents a method to detect fibrin formation based on electrical 
impedance sensing. A polydimethylsiloxane (PDMS) microfluidic device was designed 
and fabricated to detect fibrin formation in artificial blood samples (solution of fibrinogen, 
thrombin and CaCl2) by measuring changes in electrical impedance during the process of 
coagulation. The electrical measurements were performed using a lock-in amplifier. The 
optical properties of the fibrin in the microfluidic device were observed in an inverted 
microscope to confirm the clot formation. In the study, the dimensions of the microfluidic 
devices and the sensing electrodes were optimized to improve the sensitivity and to ensure 
electrical contact between the electrodes and analyte. An equivalent circuit model was 
developed to fit the change in the electrical signal of the channel accurately and to 
determine the optimal measurement frequency. The measured electrical impedances 
exhibited an expected increase with the blood coagulation. In summary, the technique and 
the device were shown promising for detecting the blood coagulation process. 
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CHAPTER ONE: INTRODUCTION 
Blood coagulation is a defense system that helps maintain the integrity of the closed 
mammalian circulatory system after blood vessel injury[1]. The complexity of the clotting 
process is evident in the fact that numerous different components are involved[2]. It has 
developed into a highly coordinated system to maintain a dynamic balance that prevents 
bleeding while excessive thrombosis, and fibrin deposition. Fibrinolysis is the essential 
step to maintain this homeostasis[ 3 ]. Because of its complexity and universality, this 
homeostasis in the body is inevitably at risk of disorder, especially for trauma patients. For 
instance, the failure to dissolve a blood clot in time leads to blockage of blood vessels and 
tissue necrosis, or the failure to form a blood clot in time leads to blood loss and thereby 
threatens life. Traumatic injuries remain to be the leading cause of death in non-elderly 
populations in North America, causing more than one-third of deaths in 1~19-year-olds[4]. 
Clinical studies have shown that fibrinolysis is a significant factor in those coagulopathic 
patients with the highest hemorrhage-related mortality[5]. Tranexamic acid (TXA) as an 
antifibrinolytic agent has been used clinically to reduce hyperfibrinolysis in order to treat 
trauma induced acute coagulopathy (TIC) with some success. However, because of the two 
worrying findings that antifibrinolytic therapy did not affect transfusion requirements and 
that the use of antifibrinolytic drugs three hours after injury increased mortality, the use of 
TXA as a clinical treatment has been controversial. Therefore, it is necessary to identify 
early whether trauma patients have symptoms of hyperfibrinolysis before treatment with 
this drug[6]. Early identification of coagulopathy factored by hyperfibrinolysis is of great 
significance in diagnosing the reason of bleeding, guiding hemostasis treatment and 
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predicting the risk of bleeding during subsequent surgery[7] [8].  
Thrombelastography (TEG) is the well-established technique to diagnose coagulopathy. 
Since Hartert first proposed thrombelastography technique more than half a century ago, it 
has developed from being predominantly used for research to a wide range of clinical 
applications[ 9 ]. Several technologies have adopted Harter’s principles: such as 
thrombelastography (TEG®) device, ROTEM® device and Sonoclot® analysis [7]. They are 
now being used in clinical trials and are faster and more effective than routine blood tests 
(prothrombin time/International Normalized Ratio, activated partial thromboplastin time, 
fibrinogen). However, they require patients to travel to those medical centers that have the 
equipment. This leads to the long time and high cost of sample preparation [7] [10]. Early 
identification of coagulopathy and bleeding risk is important for patients who is suffering 
trauma injury. A small and inexpensive device can be used in the most hospital or even on 
the ambulance for monitoring blood clotting needs to be developed. Hence, the significance 
of measuring fibrinolysis as the ultimate goal of the project is self-evident. Before 
measuring the fibrinolysis, however, measurements of fibrin formation must be made, 
because fibrinolysis can be measured on the basis of understanding the measurement of 
fibrin formation. This thesis will show the preparation work of measuring fibrinolysis—
measurements of fibrin formation. 
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CHAPTER TWO: STATE OF THE ART OF COAGULATION DETECTION 
There are many techniques to identify the clotting of blood. In addition to the viscosity 
measurement techniques already mentioned, there are many methods for measuring the 
optical, acoustic, mechanical and electrical properties of blood [11-17]. Optical methods 
measure the optical intensity changes altered by biochemical process during blood 
coagulation. Zeinab Hajjarian et al. ingeniously combined TEG and optical measurement 
techniques to determine the viscosity change during blood clotting by measuring the 
displacement of scatters and speckle fluctuation. It is how they can verify the time of 
clotting[11]. This method requires the centrifuging and separation of plasma out of the blood. 
The required instruments are relatively large, and the time and material costs are high. The 
acoustic method is to measure the amplitude and phase changes due to coagulation when 
ultrasonic waves are transmitted into blood samples, so as to derive the sound velocity, 
temperature and blood viscosity. N. Majidi et al. used a TE (Thickness Extensions) mode 
BAW (Bulk Acoustic Wave) resonator to measure the time of clotting. Impressively, the 
work they do requires only one microliter of blood[12]. The measurements of mechanical 
properties is based on moving structure a in blood samples. For instance, the motion of a 
cantilever immersed in blood samples is measured to detect the coagulation time of blood, 
or shifts of a ribbon-like magnetoelastic sensor are measured to obtain the viscosity of 
blood[13] [14] [15]. The last method is electrical sensing. Usually, this method does not require 
large equipment, which gives it opportunity to become portable and low cost. Electrical 
measurements are based on electrical permittivity and impedance to detect blood 
coagulation[16] [17].  
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The electrical sensing fits our aim to develop a low-cost device to detect the blood 
coagulation. Besides, most of the electrical sensing technique use a relatively large channel 
as a reservoir for containing the blood sample. Here, a testing method with a microscale 
dimension channel has been presented. This electronic-based approach of impedance 
measurement provides the means to use changes of impedance during clotting for detecting 
the blood coagulation. In this approach, the electrical impedance of a microfluidic channel 
is impacted by the fibrin formation in the mixture solution (i.e. fibrinogen and thrombin 
solution). 
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CHAPTER THREE: MATERIAL AND METHODOLOGY 
Section One: Experimental design 
The whole blood sample contains many components, however, the mechanism that 
directly leads to blood coagulation is the formation of fibrin. Thrombin is the key of the 
coagulation system. It can activate platelets, transform fibrinogen into fibrinogen network, 
and amplify blood coagulation by feedback[18 ]. To complete the purpose of research, 
simplify the experiment and reduce variables, artificial blood samples consisting of a 
mixture of fibrinogen and thrombin were used to substitute whole blood sample. 
Since the mixed solution of fibrinogen and thrombin was used as the artificial blood 
sample for the test, if the changes in the optical properties can be observed, it would be of 
great help for the subsequent measurements. Thus, experiments of the fibrin forming on a 
piece of microscope glass slide are necessary for testifying our hypothesis. If the optical 
properties are obvious to observe on the microscope glass slide, it can be tested in the 
microfluidic channel. After ensuring the observation of changes of optical properties, they 
can be used to verify the fibrin formation in the microfluidic channel in the device. 
The normal concentration of fibrinogen in the blood ranges from 150 mg/dL to 400 
mg/dL[19]. Therefore, the experimental concentration of fibrinogen is controlled in this 
range. However, there is no stable concentration of thrombin in the blood. Thrombin is 
produced when the body needs clots to hemostasis and broke down when it does not. 
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Therefore, as the catalyst of coagulation reaction, the concentration of thrombin is the key 
to control the coagulation rate in the experiment. 
The sensor consists of a microfluidic channel embedded in a polydimethylsiloxane 
(PDMS) was bonded to a glass substrate deposited with pre-defined gold electrodes and 
contact pads. During the experiments, two channels of different dimensions were used. The 
first one was a big channel. The cross-section of channel was a rectangle with length of 
4mm and height of 70µm. The length of the channel was 44mm. The other was refitted for 
improving the sensitivity of channel. The small channel was constructed with length of 
15mm, width of 80µm. The height of channel was designed to be 20µm. 
The channel was filled with desired solutions (buffer solution, mixture solution of 
fibrinogen and thrombin) and connected to a Lock-in Amplifier (Stanford Research SR-
830) by fine copper wires welded on the gold contact pads for sensing the voltage drop. 
The Lock-in Amplifier output (at an amplitude of 1 V) was connected to a 100 MΩ to 
create a current source. When this current passing across the channel via electrodes 1 and 
2 in the schematic diagram (Fig. 1), a four-terminal measurement technique was employed 
to measure the voltage changes during the fibrin formation in the microfluidic channel. 
Changes in voltage were measured via 3 and 4 in the schematic diagram (Fig. 1) during the 
process of fibrin formation coagulation to detect the coagulation. All the signal data was 
collected and save on the computer by LabView. After obtaining the data of changes in 
voltage, changes in electrical impedance during coagulation were calculated according to 
the equivalent circuit model we established. 
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Figure 1.  Schematic diagram of channel and electrodes 
 
Section Two: Experimental objectives 
The analyte was artificial blood samples which was the mixture solution of Hank’s 
Buffer Salt Solution (HBSS), CaCl2, Fibrinogen and Thrombin. 1X Hank’s Buffer Salt 
Solution (HBSS) without Magnesium and Calcium was used as our buffer solution. The 
control group was mixture of HBSS, CaCl2 and Fibrinogen. The concentrations of each 
component were shown as Table 1. 
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Table 1. Concentration of components 
Components Concentration 
CaCl2 1 mM 
Fibrinogen (starting) 2.72 mg/mL 
Thrombin (starting) 4nM 
Before operating experiments, the analyte should be prepared following the procedure: 
1. Started with 10 mL HBSS in the centrifuge tube. 500 µL of the solution was aspirated 
by a pipette from the centrifuge tube; the solution of calcium chloride (CaCl2) was added 
in with a concentration of 20 mM in the same volume. Vortex mixer was used to mix the 
solution completely. The HBSS buffer solution with 1 mM CaCl2 had been prepared. If 
necessary, this prepared buffer solution could be used to dilute the high concentration 
Fibrinogen solution. 
2. 500 µL the prepared HBSS buffer solution with 1 mM CaCl2 was pipetted and 
transferred in another centrifuge tube. 1 µL solution was removed by micropipette. Put 1 
µL thrombin solution with a concentration of 0.1 mM into the buffer solution by 
micropipette. Vortex mixer was used to mix the solution completely. The thrombin solution 
had been diluted with ratio of 1:500. 
3. 5mL the prepared HBSS buffer solution with 1 mM CaCl2 was pipetted and 
transferred in another centrifuge tube. 100 µL solution was pipetted; the diluted thrombin 
solution was put back with same volume by micropipette. Vortex mixer was used to mix 
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the solution completely. The thrombin solution with concentration of 4nM had been 
prepared. 
Before measurement, both prepared fibrinogen and thrombin were taken out 100 µL each 
and mixed at ratio of 1:1 in a centrifuge tube. Once putting the fibrinogen and thrombin 
together, we shook it 3 times by hand to ensure not only that the mixture was well mixed 
but that the clotting level was not high. After mixed completely, the mixture was 
immediately piped out with a syringe and expelled the air at once. When we made sure 
there was no air in the entire syringe and needle, the mixture was gently injected into the 
microchannel. 
 
Section Three: Device design and fabrication 
The microfluidic channel was designed and constructed following the conventional 
photolithography technology. A SU-8 master model of channels was patterned onto a 
polished silicon wafer by using the standard microfabrication method. 
Polydimethylsiloxane (PDMS) was poured onto the mold and subsequently cured onto the 
master mold at 90 ℃ for at least 60 minutes after mixing at ration of 1:10 and degassing. 
After cured, a slab of PDMS was removed from the master mold. A chip with the embedded 
microfluidic channel was excised from the slab, and inlet and outlet were cored with 1 mm 
diameter biopsy punch. The chip with microfluidic channel was bonded to a glass substrate 
deposited with pre-defined gold electrodes and pads after exposure to oxygen plasma. 
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Finally, the device was placed onto a hotplate set to 90 ℃ for 45 minutes. 
The dimensions of big microchannels was designed width of 4 mm and height of 70 µm. 
The length of the channel was 44 mm. (Shown as Fig. 2a) The small channel was tailored 
for improving the sensitivity of channel. It was constructed with length of 15 mm, width 
of 80 µm. The height of channel was designed to be 20 µm. (Shown as Fig. 2b) 
To fabricate the gold electrodes and contact pads onto the glass substrate, we utilized 
electrical discharge machining (EDM) technique for patterning the masks. After cleaning 
the patterned mask, it was tapped on the microscope glass slide. Using electron beam 
evaporation, we deposited 800/1000 Å chrome/gold (Cr/Au) thin film onto the substrates.  
  
Figure 2a. Photo fo the big channel we used;  
Figure 2b. photo of the small channel we used. 
 
Section Four: Optical properties 
To know the optical properties of artificial blood samples consisting of a mixture of 
fibrinogen and thrombin, the sample was observed in an inverted microscope. The optical 
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properties of the mixture are known by comparing it with a solution containing only 
fibrinogen. The mixture was prepared and pre-mixed (following the procedure of 3.2 
mentioned above) before dropped on the microscope glass slide with micropipette. The 
volume of mixture used for experiments on the microscope glass slide was about 60 µL. 
After placing the microscope slide on the inverted microscope, the resolution is adjusted 
in phase contrast mode. Photos of the optical properties of the solution of mixture are 
obtained through the screen-shot function. 
 
Figure 3a. Optical properties of buffer solution observed under the inverted microscope. 
Figure 3b. Fibrin formed in the solution on the glass slide. 
Fig. 3a and 3b are microscopic views of the optical properties of buffer solution and 
mixture solution on the glass slide. By compared with Fig. 3a and 3b, we confirm the fibrin 
can be clearly observed and distinguished from buffer solution under the inverted 
microscope. Encouraged by this result, we continued to conduct experiments to observe 
the optical properties of the solution of mixture in the microchannel. 
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Before operating the experiment in the microchannel, the cover slide was used to 
simulate the height of microchannel. As the Fig. 4 showed below, it was perfect view of 
fibrin form in the mixture solution under cover slide. 
 
Figure 4. Optical properties of fibrin formed under cover slide 
Following the microscope operation of the glass slide experiment and the mixing 
operation mentioned above, the mixed solution was injected into the microchannel and 
observed. (Fig. 5a and 5b) The first photo, Fig. 5a, was the buffer solution under the 
inverted microscope. The second one, Fig. 5b, was the mixture solution of fibrinogen and 
thrombin after clotting. The photos showed that the differences between solution with clots 
and the one without clots were obvious. However, there were some differences between 
the clotted mixture solution on the glass slide and in the microchannel: It did not look like 
fiber, and some spot were shown in the sight. The result why this difference occurred could 
be attributed to the heterogeneity of the PDMS and injection. PDMS blocks were not 
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uniform matters, therefore, they would scatter the light from the microscope and impact 
the image we observed. The part that injection impacted was the pressure and the flow are 
probably to break up, squeeze or fold the fiber chain. As a result, the fibrin in the 
microchannel looks less like "fiber" than it does in the microscopic glass. 
 
Figure 5a. Optical properties of buffer solution in the microchannel; 
Figure 5b. Optical properties of fibrin formed in the microchannel 
 
Section Five: Impedance measurements 
After all the preliminary experiments, the observability of coagulation was confirmed. 
The next experiment is to measure the impedance change of the entire microchannel. The 
fine copper wire is welded to the contact plate of the microfluidic chip and connected to 
the phase-locked amplifier by BNC cable. In this way, the microfluidic based device was 
connected to the Lock-in Amplifier and formed a closed circuit. We used four terminal 
impedance measurement. The cross section is shown as Fig. 6. The yellow square was the 
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electrode. We used two terminals as driving electrodes. The other two were sensing 
electrodes. 
 
Figure 6. Schematic diagram of cross section of microchannel 
 
The circuit we used is shown as Fig. 7 below. The resistor Rc in the figure was the 
impedance of microchannels, which was paralleled with internal and Ca of Lock-in 
Amplifier. Za represented impedance of the resistor Ra (10 MΩ) and the capacitor Ca (25 
pF) in parallel inside the Lock-in Amplifier. The Rs was an external resistor (100 MΩ) 
which connected with a Lock-in Amplifier to create a current source. Vc was the voltage 
of Rc. Vs was the power source of the Lock-in Amplifier. What we measured was the 
voltage in the microchannel, which is Vc. 
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Figure 7. Circuit diagram of measurements 
 
From this circuit, the current pass through channel can be written as: 𝐼# = %&'&((*&+,(-)'/. 
What Lock-in Amplifier measured is Vc, the voltage of Rc. From ohm’s law, 𝑉# = 𝐼#𝑅#, 
this relationship can be obtained: %/'/ = %&'&((*&+,(-)'/. The impedance of the device can be 
calculated from this equation as follow: 
𝑅# = 𝑉#𝑅2[𝑉2 − 𝑉#(𝑅2𝑍6 + 1)] 
Given that we had already known the Rs, Rc and Vs, once we got the measuring data of 
Vc, we could calculate the impedance of analyte in the channel based on the equation 
above.  
V
s
 Rc 
R
s
 
R
a
 C
a
 
Lock-in Amplifier 
V
c
 Va 
  
Za 
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CHAPTER FOUR: RESULT ANALYSIS 
Initially, we measured the impedance of buffer solution without any Fibrinogen and 
Thrombin. The operation frequency was 2 kHz based on the frequency sweeping. The time 
of impedance measurements of buffer solution was 20 minutes. After measuring the 
electrical impedance, the buffer solution was sucked out of the channel with a syringe. The 
pre-mixed mixture solution of fibrinogen and thrombin was injected into the channel and 
measure the impedance changes for 20 minutes. A typical time trace of this was shown as 
Fig. 8 below. The percentage on the right Y-axis represented the rate of changes of 
impedance in the channel. The normalization of the data was used equation below: 
dZ𝑍< = 𝑍 − 𝑍<𝑍<  
Z was the impedance data we measured. Z0 was the initial data of the measurement. This 
equation let the change of the impedance for a group start from 0%. Thus, the rate of 
changes of impedance in every group could be compared with each other. 
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Figure 8. Plots of electrical impedance of buffer solution and mixture solution at 2kHz 
Several groups of this similar data were obtained. What they have in common was that 
all the rate of changes of impedance was less than 2.5% (Fig. A1-A10 shown in the 
appendix A). Besides, as shown in the figures, the impedance change of the buffer solution 
was not significantly different from that of the mixture solution of fibrinogen and thrombin. 
Since determined by obvious optical properties that the mixture solution and buffer 
solution were different when fibrin was produced, the impedance changes of the two should 
also be significantly different. The maximum difference in the rate of changes of 
impedance was less than 2 percent.  
Because of this inconspicuous difference, we suspected the sensitivity of the channel 
was not as well as expect. The reason for our skepticism is based on the size of the channel. 
The dimensions of channel were in millimeters. Therefore, the changes of impedance 
during the fibrin formation process in the channel are likely to be less dominant than the 
changes of impedance caused by the drifting in the buffer solution itself. Based on this 
doubt, we developed the second channel to smaller size. The width of the new channel had 
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been modified to 80 µm. Impedance measurements were performed on a second device 
with a smaller channel.  
 
Figure 9a (G1). The plot of electrical impedance of buffer solution and mixture solution at 10 Hz 
for 4 hours; 
Figure 9b (G6). The plot of electrical impedance of buffer solution and mixture solution at 10 Hz 
for 2.7 hours; 
Figure 9c. The plot of electrical impedance of mixed solution of buffer solution and fibrinogen at 
10 Hz for 1.7 hours 
On the new small channel, the operating frequency was chosen to be 10 Hz based on 
frequency sweeping. The typical time traces of small channels were shown Fig. 9a, 9b and 
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9c as above. As these figures showed, the range of changes of impedance in the 
microchannel increased, which meant that the sensitivity had improved. However, the 
tendency of the impedance was still relatively random. (Fig. B1–B8 shown in the appendix 
B) Some groups had a significant increase in the impedance of the mixture solution of 
fibrinogen and thrombin, but some did not. At first, we suspect the contact of electrodes 
and analyte was not working well. Thus, the new design of electrodes was used. There 
were overlaps between electrodes to make sure the contact between analyte and electrodes. 
But the result, shown as Fig. 10, did not improve.  
 
Figure 10. The plot of electrical impedance of buffer solution and mixture solution at 10 Hz for 1 
hour. 
This result convinced us the problem was not the contact between analyte and electrodes. 
We further suspect that the measurement frequency is unreasonable. A double layer 
capacitor would form between the electrode and the analyte solution during measurement. 
The capacitance was likely to block the low-frequency current from entering the solution 
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so that the measured object is not the analyte. Thus, we decided to increase operating 
frequency. Frequency at 1 kHz was tried at first. But the plot in the Fig. 11a and 11b told 
us that the 1 kHz did not work. 
 
Figure 11a. The plot of electrical impedance of mixture solution at 1 kHz for 1 hour. 
Figure 11b. The plot of electrical impedance of mixture solution at 1 kHz for 0.75 hour. 
After operating measurements at frequency of 1 kHz, the frequency was kept increasing. 
To increase the band width of measurement, we disconnected the external 100 MΩ resistor 
and used the internal 50 Ω resistor of Lock-in Amplifier. The impedance of analyte would 
not change when the operating frequency was above 60 kHz. Based on this result, we used 
a relatively high frequency current (at 65 kHz) to avoid the possibility of impacts caused 
by double layer capacitors. The Fig. 12 showed the result of the measurements at 65 kHz. 
We ended up with three successive sets of images with increasing impedance.  
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Figure 12. The plot of electrical impedance of mixture solution at 65 kHz for 2.3 hour. 
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CHAPTER FIVE: SUMMARY and DISCUSSION 
Early verification of ability of blood coagulation and lysis of blood clots to diagnose 
whether they have a coagulopathy is vital for Trauma patients. We have shown a potential 
approach to detect fibrin formation based on electrical impedance sensing was presented. 
To confirm the optical change of artificial blood sample before and after coagulation, we 
designed experiment to observe the optical properties of fibrin formation on the glass slide 
under an inverted microscope. By analyzing of experimental results, we refitted the channel 
size to enhance the sensitivity and a more optimal operating frequency was selected.  
It should be noted that this study has examined only in vitro fibrin formation. Also, the 
measurement method we use is to let a constant current flow into the micro channel and 
measure the voltage of the channel to detect the change in the overall impedance. The 
internal power supply of the phase-locked amplifier is not an ideal voltage/current source, 
so we connect the output with a large external resistor to make it as a current source. The 
large external resistor, however, not only let the current stable but limit the bandwidth of 
measurements. Therefore, there could be two methods to improve this limit. The first 
method is to use a current source to perform experiments. The other is to increase the 
voltage of output of the Lock-in Amplifier. Finally, the skepticism of double layer capacitor 
is needed to testify.  
Based on the dimension of our microchannels, it may be possible to use plasma rather 
than whole blood for experiments in future work. In addition to the fact that using whole 
blood could block the microchannel, it may introduce extraneous variables that are 
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detrimental to the analysis of coagulation and fibrinolysis. After our device is developed, 
we envision that this is a portable and rapid detection of disposable equipment. Hopefully 
it can be used in an ambulance or in a hospital emergency laboratory. However, it is 
unrealistic to assume that our device will rapidly replace TEG technology. The reason is 
that TEG technology has been clinically used for a long time and has been repeatedly 
verified and improved. It has been very well-established and its results are very reliable. 
Therefore, if our developed devices are used for clinical application, the early stage will be 
likely to be combined with TEG technology for detection. 
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CHAPTER SIX: CONCLUSION and FUTURE WORKS 
This paper presents a potential method for measuring clotting, in which a better 
operating frequency is obtained. It is determined that the electrical impedance of the mixed 
solution increased during fibrinogen formation. As a preparatory work for measuring 
fibrinolysis, based on the impedance change results during the measurement of fibrinolysis, 
we can reasonably assume that the electrical impedance should decrease during the 
measurement of fibrinolysis. In future work, the size and shape of the microchannel can be 
refitted to reduce the flow of solution induced by injection, so as to make the solution stable 
quickly for measurement. Fibrinogen, thrombin and plasmin can be mixed to measure the 
whole process from fibrin formation to fibrinolysis. The concentration of plasmin can be 
adjusted to simulate the situation in traumatic patients with symptoms of hyperfibrinolysis. 
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APPENDIX A 
Results of big channels with operating frequency of 2 kHz. 
 
Fig A1. Impedance of buffer solution and mixture solution for group 1. 
 
Fig A2. Impedance of buffer solution and mixture solution for group 2. 
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Fig A3. Impedance of buffer solution and mixture solution for group 3. 
 
Fig A4. Impedance of buffer solution and mixture solution for group 4. 
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Fig A5. Impedance of buffer solution and mixture solution for group 5. 
 
Fig A6. Impedance of buffer solution and mixture solution for group 6. 
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Fig A7. Impedance of buffer solution and mixture solution for group 7. 
 
Fig A8. Impedance of buffer solution and mixture solution for group 8. 
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Fig A9. Impedance of buffer solution and mixture solution for group 9. 
 
Fig A10 and Fig A11. Impedance of buffer solution group 10-1 and 10-2. 
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Fig A12 and Fig A13. Impedance of buffer solution group 10-3 and 10-4. 
 
Fig A14 and Fig A15. Impedance of buffer solution group 10-5 and 10-6. 
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Fig A16. Impedance of buffer solution group 10-7. 
Fig A17. Impedance of mixture solution. 
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APPENDIX B 
Results of small channels with operating frequency of 10 Hz. 
 
Fig. B1. Impedance of mixture solution for 4 hours. 
Fig. B2. Impedance of mixture solution for 1 hour. 
 
Fig. B3. Impedance of mixture solution for 1.7 hours. 
Fig. B4. Impedance of mixture solution for 1.1 hours 
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Fig. B5. Impedance of mixture solution for 1 hour. 
Fig. B6. Impedance of mixture solution for 2.7 hours. 
 
Fig. B7. Impedance of mixture solution for 1 hour. 
Fig. B8. Impedance of mixed buffer solution and fibrinogen solution for 1.7 hours 
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Results of small channels with operating frequency of 1 kHz. 
 
Fig. B9. Impedance of mixture solution for 1 hour. 
Fig. B10. Impedance of mixture solution for 0.75 hours. 
 
Fig. B11. Impedance of mixture solution for 1 hour. 
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Results of small channels with operating frequency of 65 kHz. 
 
Fig. B12. Impedance of mixture solution for 1.75 hour. 
Fig. B13. Impedance of mixture solution for 2.3 hour. 
 
Fig. B14. Impedance of mixture solution for 1.7 hours. 
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